- Home
- DSGN vs PCB Comparison
DSGN vs PCB Comparison
Compare DSGN & PCB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DSGN
- PCB
- Stock Information
- Founded
- DSGN 2017
- PCB 2003
- Country
- DSGN United States
- PCB United States
- Employees
- DSGN N/A
- PCB N/A
- Industry
- DSGN Biotechnology: Pharmaceutical Preparations
- PCB Major Banks
- Sector
- DSGN Health Care
- PCB Finance
- Exchange
- DSGN Nasdaq
- PCB Nasdaq
- Market Cap
- DSGN 353.9M
- PCB 308.3M
- IPO Year
- DSGN 2021
- PCB N/A
- Fundamental
- Price
- DSGN $6.25
- PCB $20.40
- Analyst Decision
- DSGN Hold
- PCB Hold
- Analyst Count
- DSGN 3
- PCB 2
- Target Price
- DSGN $7.00
- PCB $22.00
- AVG Volume (30 Days)
- DSGN 208.4K
- PCB 32.8K
- Earning Date
- DSGN 11-07-2024
- PCB 01-23-2025
- Dividend Yield
- DSGN N/A
- PCB 3.53%
- EPS Growth
- DSGN N/A
- PCB N/A
- EPS
- DSGN N/A
- PCB 1.68
- Revenue
- DSGN N/A
- PCB $94,833,000.00
- Revenue This Year
- DSGN N/A
- PCB N/A
- Revenue Next Year
- DSGN N/A
- PCB $10.34
- P/E Ratio
- DSGN N/A
- PCB $12.15
- Revenue Growth
- DSGN N/A
- PCB N/A
- 52 Week Low
- DSGN $2.25
- PCB $14.50
- 52 Week High
- DSGN $7.77
- PCB $22.20
- Technical
- Relative Strength Index (RSI)
- DSGN 52.38
- PCB 42.71
- Support Level
- DSGN $5.55
- PCB $21.17
- Resistance Level
- DSGN $6.45
- PCB $21.77
- Average True Range (ATR)
- DSGN 0.56
- PCB 0.59
- MACD
- DSGN -0.04
- PCB -0.24
- Stochastic Oscillator
- DSGN 57.67
- PCB 40.40
About DSGN Design Therapeutics Inc.
Design Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the research and development of GeneTACTM molecules, which are a novel class of small-molecule gene-targeted chimera therapeutic candidates designed to be disease-modifying by addressing the underlying cause of diseases caused by inherited nucleotide repeat expansion mutations. The Company's product candidate is in Friedreich ataxia (FA), its second product candidate is in Fuchs endothelial corneal dystrophy (FECD), and it is also advancing its GeneTACTM program to address other serious nucleotide repeat-driven monogenic diseases.
About PCB PCB Bancorp
PCB Bancorp is a bank holding company, which engages in the provision of consumer and commercial banking services. It provides Personal, Business, and Loan services, which provide banking, lending, and digital, tools, home loans, and others. Also, it offers a broad range of loans, deposits, and other products and services predominantly to small and middle-market businesses and individuals.